News

Trail Begins For Diabetes Drug Maker

View Comments
A picture taken on June 9, 2011 in a pharmacy in France, shows a pack of Actos antidiabetic drug (Pioglitazone) from Takeda Japanese laboratory.

 (photo: JEFF PACHOUD/AFP/Getty Images)

A picture taken on June 9, 2011 in a pharmacy in France, shows a pack of Actos antidiabetic drug (Pioglitazone) from Takeda Japanese laboratory.

(photo: JEFF PACHOUD/AFP/Getty Images)

tate south Tate South
Email Tate at tate.south@cbsradio.com
Read More

CBS Las Vegas (con't)

Affordable Care Act Updates: CBSLasVegas.com/ACA

Health News & Information: CBSLasVegas.com/Health

Get Breaking News First

Receive News, Politics, and Entertainment Headlines Each Morning.
Sign Up

(Las Vegas, NV)  —  Opening statements are scheduled Monday morning in a lawsuit against the maker of the diabetes drug Actos.

Two Las Vegas Valley women in their 80’s allege the maker, Takeda Pharmaceuticals, failed to highlight the risk of bladder cancer.

According to court documents, both women developed bladder cancer in 2012. One had been taking Actos for about two years, the other for about 14 months.

Attorney Robert Eglet, who represents one of the women, says he’ll seek a multi-billion dollar judgement, which would be the largest in Nevada history.

The trial is expected to last between eight and ten weeks.

The Japanese maker of Actos says it’s “committed to patient safety and is confident” in the drug’s “therapeutic benefits”.

View Comments
blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 1,080 other followers